Diaceutics (LON:DXRX) Stock Price Down 0.5%

Diaceutics PLC (LON:DXRX) was down 0.5% on Tuesday . The stock traded as low as GBX 103 ($1.27) and last traded at GBX 103 ($1.27). Approximately 66,364 shares changed hands during mid-day trading, an increase of 10% from the average daily volume of 60,601 shares. The stock had previously closed at GBX 103.50 ($1.28).

Analyst Ratings Changes

Separately, Canaccord Genuity Group restated a “buy” rating and issued a GBX 150 ($1.85) target price on shares of Diaceutics in a research report on Thursday, March 21st.

Diaceutics Stock Performance

The firm has a 50 day simple moving average of GBX 101.41 and a 200-day simple moving average of GBX 94.53. The company has a debt-to-equity ratio of 3.07, a current ratio of 7.99 and a quick ratio of 9.92. The company has a market cap of £87.22 million, a price-to-earnings ratio of 10,500.00 and a beta of 0.42.

Insiders Place Their Bets

In other Diaceutics news, insider Peter Keeling sold 750,000 shares of the firm’s stock in a transaction on Thursday, March 28th. The stock was sold at an average price of GBX 102 ($1.26), for a total transaction of £765,000 ($944,911.07). In other news, insider Graham Paterson acquired 33,564 shares of the company’s stock in a transaction dated Wednesday, March 6th. The stock was acquired at an average cost of GBX 99 ($1.22) per share, with a total value of £33,228.36 ($41,042.93). Also, insider Peter Keeling sold 750,000 shares of Diaceutics stock in a transaction on Thursday, March 28th. The shares were sold at an average price of GBX 102 ($1.26), for a total value of £765,000 ($944,911.07). 36.31% of the stock is owned by insiders.

Diaceutics Company Profile

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.